Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry
LDL-C target attainment is low in patients with SI, especially among women, despite high cardiovascular risk. The use of a greater number of LLTs, including statins, is not associated with reduced quality of life but is associated with lower LDL-C levels.
Authors
- Stephan H. Schirmer (ORCID: https://orcid.org/0000-0003-2370-8872)
- Oliver Weingärtner (ORCID: https://orcid.org/0000-0002-0236-206X)
- Wolfgang Köenig (ORCID: https://orcid.org/0000-0002-2064-9603)
- Andrea Baessler (ORCID: https://orcid.org/0000-0001-7561-1007)
- Paulina Stürzebecher (ORCID: https://orcid.org/0000-0001-5297-7137)
- Ursula Kassner (ORCID: https://orcid.org/0000-0002-4536-7063)
- Ulrike Schatz (ORCID: https://orcid.org/0000-0001-8009-9482)
- Ulrich Laufs (ORCID: https://orcid.org/0000-0003-2620-9323)
- Julius L. Katzmann (ORCID: https://orcid.org/0000-0002-2457-1129)
- Christina Mateev
- Ole Frenzel
- Ionna Gouni-Berthold
- Irina Müller-Kozarez
Institutions
- University of Cologne (DE)
- Universität Ulm (DE)
- University Hospital Regensburg (DE)
- Zimmer Biomet (Germany) (DE)
- University Hospital Leipzig (DE)
- German Centre for Cardiovascular Research (DE)
- Jena University Hospital (DE)
- Klinik und Poliklinik für Neurologie (DE)
- Deutsches Herzzentrum München (DE)
- University Hospital Cologne (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.ajpc.2025.100953
- Citations
- 5
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 10.03
Funders
- Amgen
- Novartis
- Universität Leipzig
- Novartis Pharma
- Medizinische Fakultät, Universität Leipzig
- Daiichi Sankyo Europe